CYPB

Cypress Bioscience Sets Three Week Closing High - 09/26 - 08:27 AM ET

JEFFERIES CUTS CYPRESS BIOSCIENCE PRICE TARGET TO $20 FROM $30; KEEPS BUY RATING - 09/25 - 06:59 AM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 03/18 - 08:49 PM ET

Cypress Bioscience To Present At Cowen & Company 28th Annual Health Care Conference; Webcast At 2:25 PM - 03/18 - 02:12 PM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 03/17 - 08:42 PM ET

Cypress Bioscience Turns To Profit In Q4 - Update - 03/17 - 02:16 PM ET

Cypress Bioscience Swings To Profit In Q4 - Quick Facts - 03/17 - 06:44 AM ET

Cypress Bioscience Posts Q4 Profit Per Share Of $0.08 Vs Loss $0.03 Last Year - 03/17 - 06:31 AM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 03/14 - 08:50 PM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 03/13 - 09:01 PM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 03/13 - 08:46 PM ET

Cypress Bioscience acquires Proprius - 03/05 - 05:10 AM ET

Cypress to acquire Proprius Pharmaceuticals - 02/25 - 10:37 AM ET

Cypress Bioscience to buy Proprius Pharmaceuticals for upfront $37.5M - 02/25 - 08:28 AM ET

CYPRESS BIOSCIENCE TO BUY PROPRIUS PHARMACEUTICALS - 02/25 - 08:04 AM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 02/11 - 08:44 PM ET

FOREST AND CYPRESS BIOSCIENCE'S MILNACIPRAN USED TO TREAT FIBROMYALGIA SYNDROME - 12/31 - 08:47 AM ET

Cowen & Co. Starts Cypress Bioscience At Neutral - 12/20 - 09:28 AM ET

BlackHorse Capital Discloses 5.5% Stake in Cypress Bioscience (CYPB) (si) - 11/19 - 12:35 PM ET

Cypress Bioscience Inc (CYPB) Corporate Event Announcement Notice - 11/10 - 08:45 PM ET

Page 1 of 1     1     Previous  |  Next

<< Back to Stock Index